Aidapak Recalls Aspirin EC Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling Aspirin EC tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that might cause temporary or medically reversible adverse health consequences. The hazard is a labeling error (label mixup) without reported injuries, fitting the Moderate severity criteria for minor labeling errors or voluntary precautionary recalls.
Plain-English summary
Aidapak Services, LLC is recalling specific lots of Aspirin EC, Tablet, 325 mg, Over The Counter. The recall was initiated because the tablets may have been mislabeled as other drugs, including Multivitamin/Multimineral Chew Tablets, Diltiazem HCl ER Capsules, and Aspirin Tablets. The affected product is identified by NDC 00904201360 and contains 499 tablets.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall covers five specific pedigree codes with expiration dates ranging from May 9, 2014, to June 21, 2014. Consumers should check their medication packaging for these specific pedigree codes and expiration dates.
If consumers have the affected product, they should stop using it and contact their pharmacist or the recalling firm for instructions on how to return the product. This recall is a precautionary measure to prevent patients from taking the wrong medication.
The recalled product
- Product
- ASPIRIN EC, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201360.
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 499
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- ASPIRIN EC
- Tablet
- 325 mg has the following codes: Pedigree: AD30180_13
- EXP: 5/9/2014
- Pedigree: AD52378_1
- EXP: 5/17/2014
- Pedigree: W003356
- EXP: 6/19/2014
- Pedigree: W003526
- EXP: 6/21/2014
- Pedigree: AD39588_1
- EXP: 5/13/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02